3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDIV
1
Study Type
Interventional
80
Observational
1
Sponsor
Cancer Type
Thoracic
1
Genitourinary
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
13
Melanoma
11
Lung Neoplasms
6
Squamous Cell Carcinoma of Head and Neck
5
Neoplasms
5
Head and Neck Neoplasms
3
Carcinoma, Renal Cell
3
Colorectal Neoplasms
2
Carcinoma, Hepatocellular
2
Biliary Tract Neoplasms
2
Urinary Bladder Neoplasms
1
Uncommon Pathological Types of Lung Cancer
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Skin Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcopenia
1
Prostatic Neoplasms
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Pancreatic Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasm Metastasis
1
NSCLC
1
Motor Activity
1
Lung Squamous Cell Carcinoma Stage IV
1
Lung Diseases, Interstitial
1
Liver Diseases
1
Kidney Neoplasms
1
Interventions
Blood Specimen Collection
17
Pancreaticoduodenectomy
15
Surveys and Questionnaires
11
Endoscopic Ultrasound-Guided Fine Needle Aspiration
10
Observation
9
Biopsy
8
Specimen Handling
6
Pancreatectomy
6
Gemcitabine
6
Data Collection
6
Surgical Procedures, Operative
5
Magnetic Resonance Spectroscopy
5
Endosonography
5
Electroporation
5
Biopsy, Fine-Needle
5
Neoadjuvant Therapy
4
Magnetic Resonance Imaging
4
Liquid Biopsy
4
Interviews as Topic
4
Immunologic Techniques
4
Immunohistochemistry
4
Drug Therapy
4
folfirinox
3
Fluorouracil
3
Cholangiopancreatography, Endoscopic Retrograde
3
Albumin-Bound Paclitaxel
3
irinotecan sucrosofate
2
Taxes
2
Sulfonylurea Compounds
2
Secretin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Pancreatic Neoplasms
×
pembrolizumab
×
Clear all
NCT03695835
2020-07-22
NIRPA
Gary Onik MD
Completed
27 enrolled